Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
01/02/2003 | EP1270567A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
01/02/2003 | EP1270549A1 Polymer-immobilized alpha-iminoester |
01/02/2003 | EP1268498A1 Cardioprotective phosphonates and malonates |
01/02/2003 | EP1268482A1 Pyranoindoles for treating glaucoma |
01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
01/02/2003 | EP1268408A1 Arthropodicidal carboxanilides |
01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
01/02/2003 | EP1073654A4 2,3-olefinic epothilone derivatives |
01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
12/31/2002 | US6500962 Production method of α-methylene-γ-butyrolactones |
12/31/2002 | US6500953 Preparation of camptothecin and nothapodytine derivatives |
12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
12/31/2002 | US6500843 Inhibitors of rotamase enzyme activity |
12/31/2002 | US6500824 Psychosis, or paralysis due to ischemic spinal cord injury. |
12/27/2002 | WO2002102978A2 Human growth hormone antagonists |
12/27/2002 | WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof |
12/27/2002 | WO2002102793A2 Quinazolinediones as antibacterial agents |
12/27/2002 | WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents |
12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
12/27/2002 | WO2002088127A3 Triazolopyrimidines |
12/27/2002 | WO2002074776A3 Highly purified and crystalline form of harringtonine |
12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
12/27/2002 | CA2449977A1 Human growth hormone antagonists |
12/27/2002 | CA2446963A1 Quinazolinediones as antibacterial agents |
12/26/2002 | US20020198407 Antiallergy agents and bronchodilators |
12/26/2002 | US20020198236 Small organic molecule regulators of cell proliferation |
12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
12/26/2002 | US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity |
12/26/2002 | US20020198141 Molecular conjugates for use in treatment of cancer |
12/26/2002 | US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally |
12/26/2002 | US20020197439 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer |
12/25/2002 | CN1387532A Naphthopyrans with heterocyclic in 5,6-position, preparation, and compositions and matrices contg. them |
12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
12/25/2002 | CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them |
12/25/2002 | CN1097055C Taxena derivs., preparation thereof formulation contg. them |
12/25/2002 | CN1097054C Tricyclic pyrazole derivs. and composition |
12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
12/24/2002 | US6498257 2,3-olefinic epothilone derivatives |
12/24/2002 | US6498251 Tetrahydrobenzindole derivatives |
12/24/2002 | US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis |
12/24/2002 | US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis |
12/24/2002 | US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile |
12/19/2002 | WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
12/19/2002 | WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
12/19/2002 | WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
12/19/2002 | WO2002100832A1 Isoquinoline compounds having antiinfective activity |
12/19/2002 | WO2002100319A2 Method for cleaning hard gelatine capsules |
12/19/2002 | WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE |
12/19/2002 | WO2002083651A3 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
12/19/2002 | WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
12/19/2002 | WO2002060894A3 Sulfonamide lactam inhibitors of factor xa |
12/19/2002 | WO2002050082A3 Inhibitors of papilloma virus |
12/19/2002 | US20020193598 7-(trialkylsilylalkyl)-camptothecin of given formula by cyclizing a 4-hydroxy-6-halo,7-(trialkylsilylalkyl)-3,4,7,8-tetrahydro-1h-pyrano(3,4 -c)pyridin-3,8-dione with an aryl isonitrile |
12/19/2002 | US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases |
12/19/2002 | US20020193387 As antimalarial agent |
12/19/2002 | US20020193366 Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists |
12/19/2002 | US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation |
12/19/2002 | DE10115227A1 Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren Optical data storage medium in the information layer containing a light absorbing compound having a plurality of chromophoric centers |
12/19/2002 | CA2450625A1 Isoquinoline compounds having antiinfective activity |
12/19/2002 | CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
12/18/2002 | EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them |
12/18/2002 | EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them |
12/18/2002 | EP1265902A1 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis |
12/18/2002 | EP1265878A1 A process for the preparation of epothiline analogs and intermediates |
12/18/2002 | EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii) |
12/18/2002 | CN1385432A Method for purifying tetrodotoxin |
12/18/2002 | CN1385431A Process for large-scale preparing tetrodotoxin high-purity monomer |
12/18/2002 | CN1385422A Process for preparing 2-azadihydroxy bicycle heptane compound |
12/18/2002 | CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine |
12/18/2002 | CN1096463C Procss for producing ecteinascidin and intermediate of said process |
12/18/2002 | CN1096462C 7,12-dioxabenz [a] anthracene compounds, process for preparing them and pharmaceutical compositions containing them |
12/17/2002 | US6495555 Tricyclic Δ-3-piperidines as α2-antagonists |
12/16/2002 | WO2004055020A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
12/12/2002 | WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins |
12/12/2002 | WO2002098868A1 Epothilone derivatives |
12/12/2002 | WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
12/12/2002 | WO2002098863A1 Fused imidazole derivative |
12/12/2002 | WO2002098860A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
12/12/2002 | WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
12/12/2002 | WO2002098424A1 Novel anti-infectives |
12/12/2002 | WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma |
12/12/2002 | US20020188136 Pesticides and herbicides |
12/12/2002 | US20020188124 Novel spiro compounds |
12/12/2002 | US20020188014 Polymorphs of an epothilone analog |
12/12/2002 | US20020187994 New compounds |
12/12/2002 | US20020187992 Prodrugs via acylation with cinnamate |
12/12/2002 | US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline |
12/12/2002 | US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |